Showing results (111-120 of 187) with videos related to

Sort By:
Pageof 19
BMJ Open|December 29, 2022
Multicentre single-arm phase II trial evaluating the safety and effiCacy of Panitumumab and iRinOtecan in NeoRAS Wild-type mEtaStatic colorectal cancer patientS (C-PROWESS trial): study protocolHiroki Osumi, Naoki Ishizuka, Atsuo Takashima, et al.
Anti-Cancer Drugs|June 25, 2016
Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the gastrointestinal tractTomonori Araki, Atsuo Takashima, Tetsuya Hamaguchi, et al.
Plos One|September 24, 2021
Tumor growth rate during re-challenge chemotherapy with previously used agents as salvage treatment for metastatic colorectal cancer: A retrospective studyMasashi Ishikawa, Atsuo Takashima, Yusuke Nagata, et al.
British Journal of Cancer|June 17, 2022
Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancerTaiki Hashimoto, Daisuke Takayanagi, Junpei Yonemaru, et al.
BMC Cancer|October 23, 2019
Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumabKen Masuda, Hirokazu Shoji, Kengo Nagashima, et al.
The Oncologist|March 27, 2014
Determination of prognostic factors in Japanese patients with advanced gastric cancer using the data from a randomized controlled trial, Japan clinical oncology group 9912Daisuke Takahari, Narikazu Boku, Junki Mizusawa, et al.
Scientific Reports|March 3, 2023
Comparison of clinicopathological and genomic profiles in anal squamous cell carcinoma between Japanese and Caucasian cohortsTakahiko Ito, Daisuke Takayanagi, Shigeki Sekine, et al.
Anticancer Research|April 4, 2021
Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib TreatmentYusuke Niisato, Toshikazu Moriwaki, Shota Fukuoka, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 2, 2016
Value of KRAS, BRAF, and PIK3CA Mutations and Survival Benefit from Systemic Chemotherapy in Colorectal Peritoneal CarcinomatosisYusuke Sasaki, Tetsuya Hamaguchi, Yasuhide Yamada, et al.
BMJ Open|October 8, 2020
Hydrocolloid dressing as a prophylactic use for hand-foot skin reaction induced by multitargeted kinase inhibitors: protocol of a phase 3 randomised self-controlled studySadamoto Zenda, Asako Ryu, Atsuo Takashima, et al.
Pageof 19